Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 12 min 46 sec ago

Cold Plasma Used In World's First Clinical Surgical Procedure Performed To Selectively Kill Cancer Tumor Cells

Thu, 04/16/2015 - 14:15
US Medical Innovations Successfully Completes Innovative Stage 4 Colon Cancer Surgery To Remove Tumor And Eradicate Cancerous Tissue Remnants While Sparing Normal Tissue TAKOMA PARK, Md., April 16, 2015 -- (Healthcare Sales & Marketing Network) -- A su...
Devices, Oncology
US Medical Innovations, Canady Helios, cold plasma, Canady Hybrid Plasma

Ovid Therapeutics Appoints Dr. Jeremy Levin as Chief Executive Officer

Thu, 04/16/2015 - 14:07
Dr. Levin joins Ovid Therapeutics to build a world-leading neurology company focused on rare and orphan diseases of the brain NEW YORK--(Healthcare Sales & Marketing Network)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company foc...
Biopharmaceuticals, Neurology, Personnel
Ovid Therapeutics

Sequana Medical signs collaboration agreement with Fresenius Medical Care for the marketing and distribution of the alfapump(R) system

Thu, 04/16/2015 - 13:57
ZURICH--(Healthcare Sales & Marketing Network)--Sequana Medical, a Swiss-based medical device company, announced today that it has entered into an agreement with Fresenius Medical Care to commercialize its innovative alfapump system. The alfapump system...
Devices, Distribution
Sequana Medical, Fresenius Medical Care, alfapump, ascites

Peter Falzon Joins Avellino Lab USA as Chief Executive Officer

Wed, 04/15/2015 - 15:46
Genetic Test for Refractive Surgery Safety has Screened Nearly a half-million Patients for Granular Corneal Dystrophy with 450 Positive Results MENLO PARK, Calif., April 15, 2015 -- (Healthcare Sales & Marketing Network) -- Avellino Lab USA, developer ...
Diagnostics, Ophthalmology, Personnel
Avellino Lab, Granular Corneal Dystrophy

InspireMD Announces Completion of Sales Restructuring Program

Wed, 04/15/2015 - 15:43
BOSTON, April 15, 2015 -- (Healthcare Sales & Marketing Network) -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced the completion of its ...
Devices, Interventional, Cardiology, Distribution
InspireMD, embolic protection, MGuard

Tenax Therapeutics Provides Clinical and Corporate Update

Wed, 04/15/2015 - 15:35
Hosted Analyst Day on April 13 with levosimendan clinical and development experts Provided enrollment progress update for ongoing LEVO-CTS and LeoPARDS trials Announced change in fiscal year end MORRISVILLE, N.C.--(Healthcare Sales & Marketing Net...
Biopharmaceuticals, Cardiology
Tenax Therapeutics, levosimendan

Hansen Medical(R) Receives CE Mark for Magellan(TM) 10Fr Robotic Catheter

Tue, 04/14/2015 - 16:50
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the Company's Magellan™ 10Fr Robotic Catheter has received European Conformity (CE) Marking f...
Devices, Interventional, Regulatory
Hansen Medical, Magellan, Robotic Catheter

Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs

Tue, 04/14/2015 - 16:44
Dr Joanne Quan, M.D., as Chief Medical Officer Dr Shelly Xiong, Ph.D., as Vice President of Regulatory Affairs PALO ALTO, Calif., April 14, 2015 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Incorporated, a biopharmaceutical...
Biopharmaceuticals, Personnel
Eiger BioPharmaceuticals, lonafarnib, Hepatitis Delta Virus

Prime Therapeutics names Jim DuCharme president and CEO

Tue, 04/14/2015 - 15:36
DuCharme served as Prime's CFO since 2012 ST. PAUL, Minn., April 14, 2015 -- (Healthcare Sales & Marketing Network) -- Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving more than 26 million members, announced today that its board of di...
Biopharmaceuticals, Personnel
Prime Therapeutics

Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel

Tue, 04/14/2015 - 15:33
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Infinity Pharmaceuticals, Inc. (INFI) today announced that Sujay Kango has joined the company as executive vice president, chief commercial officer and Winston “K.C.” Lam has joined as executive vic...
Biopharmaceuticals, Personnel
Infinity Pharmaceuticals

Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years

Mon, 04/13/2015 - 15:41
LILETTA™ Now Available in Doctors' Offices and Through Public Health Clinics DUBLIN and SAN FRANCISCO, April 13, 2015 -- (Healthcare Sales & Marketing Network) -- Actavis plc (ACT), a leading global pharmaceutical company and leader in women's health c...
Biopharmaceuticals, Product Launch
Actavis, Medicines360, LILETTA, levonorgestrel, contraceptive

RTI Surgical(R) Announces Agreement with Novation, One of the Nation’s Leading Healthcare Services Companies

Mon, 04/13/2015 - 15:36
ALACHUA, Fla.--(Healthcare Sales & Marketing Network)--RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading global surgical implant company, announced a new agreement with Novation, a health care services company with more than 100,000 members and affiliates o...
Devices, Surgery, Group Purchasing
RTI Surgical, Novation

Ultragenyx Appoints Daniel G. Welch to Board of Directors

Mon, 04/13/2015 - 15:33
NOVATO, Calif., April 13, 2015 -- (Healthcare Sales & Marketing Network) -- Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the appointment of...
Biopharmaceuticals, Personnel
Ultragenyx Pharmaceutical

Takeda Announces Appointment of New President of U.S. Business Unit

Mon, 04/13/2015 - 15:31
DEERFIELD, Ill., April 13, 2015 -- (Healthcare Sales & Marketing Network) -- Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA") announced today that Ram...
Biopharmaceuticals, Personnel
Takeda Pharmaceutical

Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal

Mon, 04/13/2015 - 15:27
NEWARK, Calif., April 13, 2015 -- (Healthcare Sales & Marketing Network) -- Depomed, Inc. (DEPO) today announced it has entered into a settlement agreement with Actavis, Inc. in Depomed's patent infringement litigation related to Actavis's Abbreviated New...
Biopharmaceuticals, Generics, Litigation
Depomed, Actavis, Gralise, gabapentin

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong